Viridian Therapeutics Inc NASDAQ:VRDN:
VIRIDIAN THERAPEUTICS ANNOUNCES U.S. FDA APPROVAL AND LAUNCH OF LUMVOA™ (VELIGROTUG-VVZE) FOR THE TREATMENT OF THYROID EYE DISEASE
VIRIDIAN THERAPEUTICS - TO LAUNCH LUMVOA IMMEDIATELY
Reuters
Viridian Therapeutics Announces U.S. FDA Approval And Launch Of Lumvoa™ (Veligrotug-Vvze) For The Treatment Of Thyroid Eye Disease
- Sources
- Reuters
- Markets
- Stocks
- Active symbols
- NASDAQ:VRDN
- Language
- English
Viridian Therapeutics Inc NASDAQ:VRDN: